News
Phesi Collaborates with Alfasigma on Digital Transformation Project for Clinical Development and Commercialization
Phesi Inc., a leading provider of AI-based clinical development analytics products and solutions, is showcasing its data-driven clinical development approach at SCOPE Virtual Summit for Clinical Operations Executives 2021, in a case study session with international pharmaceutical company, Alfasigma....
News
AMRI Joins Network of Approved Manufacturers of Lipid Excipients for Pfizer-BioNTech COVID-19 Vaccine
Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, announced that the company has been chosen to support the development and manufacture of lipid excipients for the Pfizer-BioNTech COVID-19 vaccine.
For the...
News
Malvern Panalytical’s new Aeris: a compact XRD system making a big impact
Malvern Panalytical, a leading analytical instruments and services supplier, launches a new version of its Aeris compact X-ray diffractometer (XRD). Aeris is a small-footprint system with a big heart, and even bigger ambitions. This new version contains capabilities previously...
News
Moderna Announces Additional Capital Investments to Increase Global Manufacturing Capacity for COVID-19 Vaccine
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announces it is making new capital investments to increase capacity at its owned and partnered manufacturing facilities, which it expects will increase global 2022 capacity to approximately...
Clinical Trials
AiCure, OncoBay Clinical Partner to Improve Patient Care, Optimize Drug Development
AiCure and OncoBay Clinical announced a partnership to provide oncology sponsors with scalable, AI-powered insights to improve patient care and optimize drug development. A subsidiary of the Moffitt Cancer Center, OncoBay will make AiCure's proprietary AI platform available for...
News
Sygnature Creates Second Integrated Drug Discovery Site at Alderley Park
Sygnature Discovery has begun expanding into new state of the art laboratories at Alderley Park, Cheshire, adding Chemistry and Biology expertise to its DMPK and Translational Oncology teams already present on the site.
Creating truly integrated interdisciplinary teams, co-located in...
News
AMRI Joins Network of Approved Manufacturers of Lipid Excipients for Pfizer-BioNTech COVID-19 Vaccine
Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, announced that the company has been chosen to support the development and manufacture of lipid excipients for the Pfizer-BioNTech COVID-19 vaccine.
For the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















